{"first_name":"Geert","last_name":"Cauwenbergh","permalink":"geert-cauwenbergh","crunchbase_url":"http://www.crunchbase.com/person/geert-cauwenbergh","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Sat Apr 16 07:13:37 UTC 2011","updated_at":"Sat Apr 16 07:19:40 UTC 2011","overview":"<p>Dr. Geert Cauwenbergh is the Founder of Phase123, a company that is focused on bringing together investigators and sponsors for drug development and clinical studies. Dr. Cauwenbergh was the Founder and CEO of Barrier Therapeutics, acquired in 2008 by Stiefel Laboratories, Inc., the world&#8217;s largest independent pharmaceutical company specializing in dermatology. Dr. Cauwenbergh has held various executive positions with Johnson and Johnson, has authored over 100 publications and co-authored several books. Dr. Cauwenbergh received his Ph.D. in Medical Sciences from the Catholic University of Leuven, where he completed his Masters and undergraduate work.</p>","image":{"available_sizes":[[[100,114],"assets/images/resized/0013/0816/130816v1-max-150x150.jpg"],[[100,114],"assets/images/resized/0013/0816/130816v1-max-250x250.jpg"],[[100,114],"assets/images/resized/0013/0816/130816v1-max-450x450.jpg"]],"attribution":""},"degrees":[{"degree_type":"Ph.D.","subject":"Medical Sciences","institution":"Catholic University","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Executive Chairman","firm":{"name":"ECI Biotech","permalink":"eci-biotech","type_of_entity":"company","image":{"available_sizes":[[[104,106],"assets/images/resized/0013/0809/130809v1-max-150x150.jpg"],[[104,106],"assets/images/resized/0013/0809/130809v1-max-250x250.jpg"],[[104,106],"assets/images/resized/0013/0809/130809v1-max-450x450.jpg"]],"attribution":null}}},{"is_past":false,"title":"President and Chief Executive Officer","firm":{"name":"RXi Pharmaceuticals","permalink":"rxi-pharmaceuticals","type_of_entity":"company","image":{"available_sizes":[[[150,35],"assets/images/resized/0012/4572/124572v1-max-150x150.png"],[[250,58],"assets/images/resized/0012/4572/124572v1-max-250x250.png"],[[255,60],"assets/images/resized/0012/4572/124572v1-max-450x450.png"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}